NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -180.54% | 51.67% | 45.77% | 20.47% | 153.37% |
| Total Depreciation and Amortization | 0.61% | 0.31% | 5.55% | 7.72% | 10.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 829.07% | -2.87% | -88.58% | -129.15% | -106.73% |
| Change in Net Operating Assets | 1.83% | -122.19% | -210.48% | 871.81% | -125.95% |
| Cash from Operations | -1,597.98% | 42.79% | 38.00% | 97.42% | 105.46% |
| Capital Expenditure | -67.21% | 71.27% | -193.92% | 89.81% | 34.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -67.21% | 71.27% | -193.92% | 89.81% | 34.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 446.51% | -80.23% | -- |
| Repurchase of Common Stock | 68.14% | 71.43% | 92.51% | -847.79% | 16.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.40% | -95.94% | -1,172.97% | 49.71% | -1,221.22% |
| Cash from Financing | 129.02% | -97.37% | 427.17% | -87.49% | -142.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -823.79% | -818.89% | 924.77% | 175.48% | 87.67% |